Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation

BACKGROUND: Guideline recommendations for oral anticoagulation (OAC) in patients with atrial fibrillation (AF) are based on CHA(2)DS(2)‐VASc score alone. Patients with cardiac implantable electronic devices provide an opportunity to assess how the interaction between AF duration and CHA(2)DS(2)‐VASc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplan, Rachel M., Ziegler, Paul D., Koehler, Jodi, Landman, Sean, Sarkar, Shantanu, Passman, Rod S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955365/
https://www.ncbi.nlm.nih.gov/pubmed/33252286
http://dx.doi.org/10.1161/JAHA.120.018378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955365/
https://www.ncbi.nlm.nih.gov/pubmed/33252286
http://dx.doi.org/10.1161/JAHA.120.018378

Ejemplares similares